Clinical Trial Update: A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer

View source ↗

Summary

A recruiting study evaluating switching between two targeted chemotherapy strategies (HP+Chemotherapy vs HPy+Chemotherapy) after progression in HER2-positive ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HP
• HPy

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Breast Cancer | Status: RECRUITING